Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2006

View Archived Issues

BPC-157 evaluated in model of anastomosis healing

DDP-733 increases lower esophageal sphincter pressure in cats

Cardiome updates progress of RSD-1235 through quarter

Medarex offers overview of inhouse and partnered programs

URB-597 has antidepressant activity in animal models

Cannabinoid receptor 2 a target for osteoporosis

In vitro studies show osteoporosis treatment potential of kobophenol A

Pagoclone produces decrease in severity of stuttering

7TM Pharma acquires CareX

Clinical results support further development of BAY 79-4980 for hemophilia A

EnVivo sets out plans for drug development progression

Proof-of-concept study for NicVAX in smoking cessation

AST-120 studied in North America and Europe for fistulizing Crohn's disease

VQD-002 studied in new phase I/IIa trial for solid tumors

Preclinical safety studies completed for oral calcitonin program

Enrollment completed in MERLIN TIMI-36 study of ranolazine

Second U.S. phase III study of Zadaxin in HCV fails to meet primary endpoint

Eraxis launched in U.S. for antifungal indications

Novel therapeutic agents for respiratory disorders disclosed in recent patent literature

Recent patents describe novel agents for anxiety, depression, psychosis, etc.

New treatment options for inflammatory disorders disclosed

Ganfort approved for glaucoma in E.U.

Iplex now available for primary IGFD

Avastin filed for first-line treatment of metastatic breast cancer

Accelerated approval for Thalomid in multiple myeloma

Seasonique extended-cycle oral contraceptive receives FDA approval

Cubicin approved for S. aureus bloodstream infections

Zostavax approved in U.S. for prevention of shingles

Cannabinoid CB2 receptors as a target for anxiety and substance abuse

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...